Summary
Parents at risk of bearing a child with cystic fibrosis, and who have no living affected child, often use prenatal diagnosis based on microvillar enzyme assay in second-trimester amniotic fluid samples. If enzyme levels are abnormal and the pregnancy is terminated, it is possible in principle to use the fetal tissues to establish the phase relationship of linked DNA markers for a subsequent first-trimester prenatal diagnosis. However, the probability of a fetus being affected after an abnormal microvillar enzyme test may be no greater than 80%. The strong linkage disequilibrium between haplotypes at the D7S23 locus and the cystic fibrosis gene may be used to increase this probability. If fetal tissues are homozygous for the 6.6-kb band defined by pKM.19 and PstI and also homozygous for the 2.1-kb band with pXV-2c and TaqI, the chance of being affected increases from 80% to between 95% and 97%. We regard this as being sufficiently certain for use in phase determination.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beaudet A, Spence JE, O'Brien WE, Estivill X, Farrall M, Williamson R (1988) Experience with new DNA markers for the diagnosis of cystic fibrosis. N Engl J Med 318:50–51
Boué A, Muller F, Nezelof C, Oury JF, Duchatel F, Dumez Y, Aubry MC, Boué J (1986) Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet 74:288–297
Brock DJH (eds) (1987) Workshop on the prenatal diagnosis of cystic fibrosis. In: Vogel F, Sperling K (eds) Human genetics. Proceedings of the 7th International Congress, Berlin 1986. Springer. Berlin Heidelberg New York, pp 631–633
Brock DJH, Bedgood D, Barron L, Hayward C (1985) Prospective prenatal diagnosis of cystic fibrosis. Lancet I:1175–1178
Brock DJH, Clarke HAK, Barron L (1988) Prenatal diagnosis of cystic fibrosis by microvillar enzyme assay on a sequence of 258 pregnancies. Hum Genet 78:271–275
Curtis A, Strain L, Mennie M, Brock DJH (1988) Confimation of prenatal diagnosis of cystic fibrosis by DNA typing of fetal tissues. J Med Genet 25:79–82
Estivill X, Farrall M, Scambler PJ, Bell GM, Hawley KMF, Lench NJ, Bates GP, Kruyer HC, Frederick PA, Stanier P, Watson EK, Williamson R, Wainwright BJ (1987) A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands. Nature 326:840–845
Estivill X, Scambler PJ, Wainwright BJ, Hawley KMF, Frederick PA, Short M, Baigep M, Keve J, Williamson R, Farrall M (1988) Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics 1:257–263
Marshall AJ, Burgoyne LA (1976) Interpretation of the properties of chromatin extracts from mammalian nuclei. Nucleic Acids Res 3: 1101–1110
Wainwright BJ, Scambler PJ, Schmidtke J, Watson EA, Law H-Y, Farrall M, Cooke HJ, Eiberg H, Williamson R (1985) Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature 318:384–385
White R, Woodward S, Leppert M, O'Connell P, Hoff M, Herbst J, Lalouel J-M, Dean M, Van de Woude G (1985) A closely linked genetic marker for cystic fibrosis. Nature 318:382–384
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strain, L., Curtis, A., Mennie, M. et al. Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis. Hum Genet 80, 75–77 (1988). https://doi.org/10.1007/BF00451460
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00451460